SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-14-000338
Filing Date
2014-11-06
Accepted
2014-11-06 16:32:21
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kbio-20140930x10q.htm 10-Q 1326295
2 EX-10.1 kbio-20140930ex101157536.htm EX-10.1 209423
3 EX-31.1 kbio-20140930ex311ab4b13.htm EX-31.1 17817
4 EX-31.2 kbio-20140930ex3120fd168.htm EX-31.2 18126
5 EX-32.1 kbio-20140930ex3210bfcb7.htm EX-32.1 9151
6 EX-32.2 kbio-20140930ex322022466.htm EX-32.2 9209
  Complete submission text file 0001558370-14-000338.txt   5201486

Data Files

Seq Description Document Type Size
7 EX-101.INS kbio-20140930.xml EX-101.INS 699521
8 EX-101.SCH kbio-20140930.xsd EX-101.SCH 28496
9 EX-101.CAL kbio-20140930_cal.xml EX-101.CAL 37137
10 EX-101.DEF kbio-20140930_def.xml EX-101.DEF 80220
11 EX-101.LAB kbio-20140930_lab.xml EX-101.LAB 281102
12 EX-101.PRE kbio-20140930_pre.xml EX-101.PRE 175940
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 141201152
SIC: 2834 Pharmaceutical Preparations